Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
AbbVie (ABBV), J&J's Imbruvica Gets FDA Nod for cGVHD in Kids
04:34pm, Thursday, 25'th Aug 2022 Zacks Investment Research
AbbVie (ABBV) and J&J's (JNJ) Imbruvica gets FDA nod for label expansion to treat pediatric patients with chronic graft versus host disease. It is also the first BTK inhibitor approved for use in pedi
AbbVie (ABBV), J&J's Imbruvica Gets FDA Nod for cGVHD in Kids
02:18pm, Thursday, 25'th Aug 2022
AbbVie (ABBV) and J&J's (JNJ) Imbruvica gets FDA nod for label expansion to treat pediatric patients with chronic graft versus host disease. It is also the first BTK inhibitor approved for use in pedi
Is AbbVie Stock A Buy Or A Sell With Humira Rivals Looming?
11:41am, Thursday, 25'th Aug 2022
Is AbbVie stock a buy today with its biggest medicine, Humira, soon to face biosimilar rivals in the U.S.? The post Is AbbVie Stock A Buy Or A Sell With Humira Rivals Looming?
Top Stocks To Buy Now? 3 Dividend Paying Stocks To Watch Today
11:48am, Wednesday, 24'th Aug 2022
Check out these three top dividend paying stocks in the stock market this week.
Want Passive Income? Invest In These 3 Dividend Kings
06:01am, Wednesday, 24'th Aug 2022
These companies have raised their payouts to shareholders throughout multiple recessions, military conflicts, and a global pandemic.
Joule Financial founder on low-volatility stocks: Kraft, Kinder Morgan, and Abbvie
03:51pm, Tuesday, 23'rd Aug 2022
Quint Tatro, founder and president of Joule Financial joins 'Power Lunch' to discuss stocks with low beta, stable yields and positive returns so far this year.
These 3 safe stocks yield more that 10-year Treasurys
12:15pm, Tuesday, 23'rd Aug 2022
After the volatility of early 2022 and the aggressive rate tightening by the Fed, there's a return of chatter about the “Great Rotation” – that is, a broad move among investors to reduce exposur
7 Top-Rated Large-Cap Stocks to Buy and Hold
07:45am, Tuesday, 23'rd Aug 2022
Top-rated large-cap stocks can offer a bit of security in volatile times. After the relief rally earlier this month, stocks may be in for another bout of weakness.
The 7 Best Bargain Stocks to Buy Now
12:00pm, Monday, 22'nd Aug 2022
Given the unique circumstances associated with the Covid-19 pandemic, investors may want to take a step back from the crowd and consider the best bargain stocks to buy now. To be sure, several equity-
2 Top Healthcare Stocks Defying the Bear Market
10:07am, Monday, 22'nd Aug 2022
Not all companies are struggling right now.
Which Growth Stock Is a Better Buy Right Now -- AbbVie or InMode?
09:30am, Sunday, 21'st Aug 2022
These beaten-down stocks share a favorable outlook for their aesthetic segments.
AbbVie Vs. Pfizer: Impact Of The Inflation Reduction Act On Their Future
05:48pm, Friday, 19'th Aug 2022
Pfizer's net income was $7,864 million in Q2 2022, up 131.8% QoQ. AbbVie's net income was $924 million in Q2 2022, up 20.6% year-on-year.
The 'Halftime Report' investment committee offers its dividend picks
01:40pm, Friday, 19'th Aug 2022
Favorite dividend stock picks right now. With CNBC's Frank Holland the the 'Halftime Report' investment committee, Rob Sechan, Kevin O'Leary, Richard Saperstein and Shannon Saccocia
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
09:47am, Thursday, 18'th Aug 2022
AbbVie (ABBV) has several new drugs with the potential to drive revenues once Humira loses U.S. exclusivity in 2023. Its early and mid-stage pipeline has several candidates with blockbuster potential.
3 Top Dividend Kings to Buy for the Long Haul
09:10am, Thursday, 18'th Aug 2022
You'll need to hold these stocks for many years to get the full benefit of their consistent dividend growth.
